Form 8-K - Current report:
SEC Accession No. 0001683168-25-001857
Filing Date
2025-03-25
Accepted
2025-03-25 16:01:47
Documents
14
Period of Report
2025-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 34646
2 AMENDMENT NO. 1 TO MASTER SUPPLY AGREEMENT, DATED MARCH 21, 2025, BY AND BETWEEN sonoma_ex1001.htm EX-10.1 9444
  Complete submission text file 0001683168-25-001857.txt   221643

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snoa-20250321.xsd EX-101.SCH 3026
4 XBRL LABEL FILE snoa-20250321_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE snoa-20250321_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 25768213
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)